Opto Circuits unveils latest AED in US, Canada; stock rallies 9%

MUMBAI: Shares of Opto Circuits surged over 9 per cent in early trade after its subsidiary Cardiac Science unveiled its latest automated external defibrillator (AED) to the US and Canadian markets.

“The Powerheart G5 is the first FDA-cleared AED to combine fully automatic shock delivery, dual language functionality, variable escalating energy, and fast shock times to help save a sudden cardiac arrest,” the company said in a filing to stock exchanges.

According to the company, the AED is designed to enable rescuers to swiftly provide effective, life-saving therapy to aid a person who has suffered SCA, a condition in which the heart suddenly stops beating due to irregularities in its electrical system.